Previous Close | 0.1587 |
Open | 0.1849 |
Bid | 0.1562 x 400 |
Ask | 0.1616 x 400 |
Day's Range | 0.1510 - 0.1853 |
52 Week Range | 0.1300 - 17.0000 |
Volume | |
Avg. Volume | 5,459,661 |
Market Cap | 5.31M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jun 24, 2005 |
1y Target Est | N/A |
Discover how Biolase Inc navigates market dynamics with robust revenue projections and significant operational efficiencies.
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript March 21, 2024 BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56. BIOL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the BIOLASE Fourth […]